Cluvot

Cluvot is a pharmaceutical product containing Human Coagulation Factor XIII, used to support blood clotting. This intravenous medication is essential for managing certain bleeding disorders.

Cluvot is primarily used to treat bleeding disorders by aiding in blood clotting. It is often administered to patients with congenital Factor XIII deficiency, a condition that impairs the body's ability to form stable blood clots. This medication helps to prevent excessive bleeding and supports wound healing.

Cluvot works by enhancing the blood's ability to clot, which can help reduce bleeding episodes. Patients may experience improved wound healing and a decrease in spontaneous bleeding. The effects of Cluvot are typically observed shortly after administration.

Cluvot should be administered under medical supervision to ensure proper dosage and monitoring. Patients with a history of allergic reactions to blood products should use this medication with caution. It is important to follow the prescribed administration guidelines to minimize the risk of adverse effects.

Cluvot may interact with other medications that affect blood clotting. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol consumption should be avoided as it can interfere with the medication's effectiveness.